In CLE/SLE + patients, as classified by both systems, there was greater expression of IL-1β (Fig. 1 A and B; ARC-82: p = 0.024; SLICC-12: p = 0.0143), compared to CLE/SLE- patients. The gene discussed is IL1B; the disease is systemic lupus erythematosus.